한국형 낭충봉아부패병 바이러스 감염 진단용 조성물 및 이를 이용한 진단 방법
    13.
    发明公开
    한국형 낭충봉아부패병 바이러스 감염 진단용 조성물 및 이를 이용한 진단 방법 有权
    用于诊断韩国类型的沙眼病毒的组合物及其诊断方法

    公开(公告)号:KR1020140005458A

    公开(公告)日:2014-01-15

    申请号:KR1020120072679

    申请日:2012-07-04

    CPC classification number: C12Q1/6844 C12N15/11 C12Q1/04

    Abstract: The present invention relates to a primer set for diagnosing Korea type sacbrood virus, and a method for diagnosing Korea type sacbrood virus using the primer set. The primer set for diagnosing Korea type sacbrood virus has an excellent effect of specifically extracting Korea type sacbrood virus from samples of sacbrood virus infection, thereby being used for extracting and diagnosing Korea type sacbrood virus. [Reference numerals] (AA) Lane 1-4 : Sample of honey bee infected with Korea type sacbrood virus; (BB) Lane 5-7 : Sample of honey bee infected with other type sacbrood virus; (CC) Lane 8 : Positive control group; (DD) Lane 9 : Negative control group

    Abstract translation: 本发明涉及用于诊断韩国型囊状病毒的引物组,以及使用引物组诊断韩国型囊状病毒的方法。 用于诊断韩国型sacbrood病毒的引物组具有从sacbrood病毒感染样品中特异性提取韩国型sacbrood病毒的优异效果,用于提取和诊断韩国型sacbrood病毒。 (AA)泳道1-4:用韩国型sacbrood病毒感染的蜂蜜样品; (BB)泳道5-7:用其他类型的囊状病毒感染的蜂蜜样品; (CC)泳道8:阳性对照组; (DD)泳道9:阴性对照组

    톡소플라즈마 원충증 예방 및 치료용 조성물
    14.
    发明公开
    톡소플라즈마 원충증 예방 및 치료용 조성물 无效
    用于预防和治疗粘液病的组合物

    公开(公告)号:KR1020130077278A

    公开(公告)日:2013-07-09

    申请号:KR1020110145900

    申请日:2011-12-29

    CPC classification number: A61K39/3955 A61K2039/552 Y10S424/826

    Abstract: PURPOSE: A composition for toxoplasma strongylosis prevention and treatment is provided to be used on the toxoplasma strongylosis prevention and treatment by lowering infection and removing toxoplasma strongylosis without concern for toxicity and antibiotic resistance. CONSTITUTION: A composition for toxoplasma strongylosis prevention and treatment comprises an immunoglobulin yolk obtained through inoculating the toxoplasma strongylosis antigen to an egg. The antigen comprises an additional adjuvant. The immunoglobulin yolk is included to 260-1350 micrograms/milliliters. The treatment method is to inoculate the composition containing pharmaceutically effective amount of immunoglobulin yolk to a mammal. [Reference numerals] (AA) Survival rate (%)

    Abstract translation: 目的:预防和治疗弓形体弓形虫病的组合物用于通过降低感染和去除弓形体强病毒而不受毒性和抗生素耐药性的预防和治疗弓形虫病。 构成:预防和治疗弓形体强毒素组合物包括通过将强毒素弓形虫病抗原接种到卵中获得的免疫球蛋白卵黄。 抗原包含另外的佐剂。 将免疫球蛋白蛋黄包含在260-1350微克/毫升中。 处理方法是将含有药学有效量的免疫球蛋白蛋白的组合物接种到哺乳动物。 (附图标记)(AA)存活率(%)

Patent Agency Ranking